ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy

Overview of attention for article published in BMC Cancer, May 2012

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 34 followers.

Actos can cause ERCC1 as a biomarker for bladder cancer patients likely to benefit ...: The ... http://t.co/qJ0VFusc Talk to an Attorney

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.